William H. Collier
2022
In 2022, William H. Collier earned a total compensation of $2.6M as President and Chief Executive Officer at Arbutus Biopharma Corp, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $315,536 |
|---|---|
| Option Awards | $1,712,646 |
| Salary | $606,800 |
| Other | $10,675 |
| Total | $2,645,657 |
Collier received $1.7M in option awards, accounting for 65% of the total pay in 2022.
Collier also received $315.5K in non-equity incentive plan, $606.8K in salary and $10.7K in other compensation.
Rankings
In 2022, William H. Collier's compensation ranked 1,387th out of 5,753 executives tracked by ExecPay. In other words, Collier earned more than 75.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,387 out of 5,753 | 76th |
Division Manufacturing | 691 out of 3,133 | 78th |
Major group Chemicals And Allied Products | 263 out of 1,419 | 82nd |
Industry group Drugs | 242 out of 1,320 | 82nd |
Industry Pharmaceutical Preparations | 171 out of 966 | 82nd |
Source: SEC filing on April 12, 2023.
Collier's colleagues
We found two more compensation records of executives who worked with William H. Collier at Arbutus Biopharma Corp in 2022.
News
Arbutus Biopharma Corp CEO William Collier's 2023 pay jumps 28% to $3.4M
April 10, 2024
Arbutus Biopharma Corp CEO William Collier's 2022 pay slips 18% to $2.6M
April 12, 2023
Arbutus Biopharma Corp CEO William Collier's 2021 pay rises 18% to $3.2M
April 11, 2022
Arbutus Biopharma Corp CEO William Collier's 2020 pay rises 17% to $2.7M
April 8, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020